Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Here, we examined the neuropharmacology of structurally distinct non-fentanyl NSOs, including U-47700, isotonitazene, brorphine, and N-desethyl isotonitazene, as compared to morphine and fentanyl.
We examine if the shift to the illicit market after the reformulation of OxyContin in the U.S.
This cross-sectional study investigates the impact of benzodiazepine (BZD) use in opioid agonist treatment (OAT) patients on their quality of life (QoL).
We conducted a rapid review of qualitative and quantitative peer-reviewed and grey literature publications that describe the clinical outcomes of SOS programs, as well as the perceptions of clients
We investigated the association between fentanyl injection frequency and sharing of injection equipment among people who inject drugs
We measured the prevalence of mono-use versus polysubstance use (PSU) in those who used substances in the past year, those with at least two symptoms of an SUD and in those who received treatment f
We sought to examine linkages between socioeconomic marginalization and non-fatal overdose risk in a community deeply affected by the ongoing drug poisoning crisis.
We sought to describe longitudinal trends in buprenorphine receipt and buprenorphine-waivered providers in the United States from 2003 to 2021 and measure whether the relationship between the two d
We sought to describe non-opioid overdose hospitalizations with documented OUD and examine receipt of post-discharge outpatient buprenorphine.
We examine surveillant functions of the Prison Needle Exchange Programs (PNEPs) through the first-hand experiences of thirty former prisoners who were incarcerated at one of the prisons with such a
We analyze the ongoing debate surrounding supervised injection sites in Ontario, Canada and changing policies that impact host communities.
Between 2017 and 2021 in Canada, several drug shortages occurred for Kadian© (SROM-24).
State-level drug supply surveillance systems have been limited in their ability to document and communicate the rapidly changing drug supplies which can hinder harm reduction efforts at the communi
This study aims to investigate the occurrence of Novel Psychoactive Substances (NPS) self-medication, identify the specific NPS involved, and understand the motivations behind their use.
We aimed to estimate the prevalence of encephalopathy among people who experienced a toxic drug event and examine the association between toxic drug events and encephalopathy.